For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
HEAD'S UP: Medical conferences touted as boom industry
+Opinion
HEAD'S UP: Medical conferences touted as boom industry
Tuesday 29 April 2025, 11:58 AM

Get out of those seats and into the exhibition hall – there is an economy to save
Editor Barbara Fountain looks at a novel three-headed approach to boosting tourism, health workforce and patient access to medicines
A regulation minister, a health minister and a tourism minister walked into a bar – well they didn't, but they may as well have judging by a media rel
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.